Invivo Therapeutics Holdings Stock Total Debt
NVIVDelisted Stock | USD 1.38 0.07 5.34% |
InVivo Therapeutics Holdings fundamentals help investors to digest information that contributes to InVivo Therapeutics' financial success or failures. It also enables traders to predict the movement of InVivo Stock. The fundamental analysis module provides a way to measure InVivo Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InVivo Therapeutics stock.
InVivo |
InVivo Therapeutics Holdings Company Total Debt Analysis
InVivo Therapeutics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current InVivo Therapeutics Total Debt | 949 K |
Most of InVivo Therapeutics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InVivo Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, InVivo Therapeutics Holdings has a Total Debt of 949 K. This is 99.97% lower than that of the Health Care Equipment & Supplies sector and 99.71% lower than that of the Health Care industry. The total debt for all United States stocks is 99.98% higher than that of the company.
InVivo Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InVivo Therapeutics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InVivo Therapeutics could also be used in its relative valuation, which is a method of valuing InVivo Therapeutics by comparing valuation metrics of similar companies.InVivo Therapeutics is currently under evaluation in total debt category among its peers.
InVivo Fundamentals
Return On Equity | -0.98 | |||
Return On Asset | -0.54 | |||
Current Valuation | (7.59 M) | |||
Shares Outstanding | 3.11 M | |||
Shares Owned By Insiders | 0.02 % | |||
Shares Owned By Institutions | 3.44 % | |||
Number Of Shares Shorted | 17.63 K | |||
Price To Earning | (1.90) X | |||
Price To Book | 0.1 X | |||
EBITDA | (9.8 M) | |||
Net Income | (9.33 M) | |||
Cash And Equivalents | 13.03 M | |||
Cash Per Share | 9.36 X | |||
Total Debt | 949 K | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 5.64 X | |||
Book Value Per Share | 2.87 X | |||
Cash Flow From Operations | (10.13 M) | |||
Short Ratio | 0.91 X | |||
Earnings Per Share | (3.28) X | |||
Target Price | 37.5 | |||
Beta | 0.66 | |||
Market Capitalization | 995.92 K | |||
Total Asset | 18.82 M | |||
Retained Earnings | (248.62 M) | |||
Working Capital | 15.13 M | |||
Current Asset | 20.74 M | |||
Current Liabilities | 3.31 M | |||
Z Score | -18.62 | |||
Net Asset | 18.82 M |
About InVivo Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InVivo Therapeutics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InVivo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InVivo Therapeutics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |